RxDoctor Payments Data

Angela Mills, DO

Family Medicine · Jane Lew, WVNPI 1225266208

Payments from drug & device makers

$492in general payments, 2019–2025

Across 31 payments — averaging $15.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$88
  • AstraZeneca$61
  • Novo Nordisk$52
  • Pfizer$46
  • Abbott$41
  • Merck$40
  • plus $163 from 6 others

What the payments were for

  • Food & beverage$44691%
  • Education$469%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$492 in reported general payments places this provider in the 55th percentile of 843 family medicine providers in West Virginia.

See all family medicine providers in West Virginia

Medicare billing

Part B allowed, 2024
$77,161
Medicare patients
196
Services billed
2,777

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JanuviaSitagliptin Phosphate102$150,640
JardianceEmpagliflozin67$97,594
OzempicSemaglutide59$73,051
EliquisApixaban68$51,221
MounjaroTirzepatide37$44,966
TradjentaLinagliptin18$27,101
EntrestoSacubitril/Valsartan13$23,999
Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog15$23,324
Tresiba Flextouch U-200Insulin Degludec16$22,849
Trelegy ElliptaFluticasone/Umeclidin/Vilanter13$20,933
Advair HfaFluticasone Propion/Salmeterol26$14,306
SymbicortBudesonide/Formoterol Fumarate23$13,386
Soliqua 100-33Insulin Glargine/Lixisenatide12$7,667
Budesonide13$6,529
RenvelaSevelamer Carbonate11$6,333

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
MerckJanuvia$40$150,640102 claims
Novo NordiskOzempic$52$73,05159 claims
PfizerEliquis$46$51,22168 claims
Lilly USA, LLCMounjaro$28$44,96637 claims
Sanofi-aventis U.S. LLCSoliqua 100-33, Renvela$25$14,00023 claims
AstraZenecaSymbicort$61$13,38623 claims
AbbVieSynthroid$88$2,64144 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 843 family medicine providers in West Virginia.

Other family medicine in Jane Lew

See the full list for West Virginia

Where these figures come from

Is this you, or does something look wrong? →